Skip to main content
China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.5181
-0.0418 (-7.47%)
At close: Nov 13, 2026, 4:00 PM
0.5215
+0.0034 (0.66%)
After-hours: Nov 13, 2026, 7:09 PM EST

China Pharma Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4.47-3.19-4.74-3.08-3.97-3.4
Depreciation & Amortization
3.051.582.682.752.73.09
Other Amortization
-----0.25
Loss (Gain) From Sale of Assets
0--0.05--
Stock-Based Compensation
----0.080.02
Provision & Write-off of Bad Debts
-13.67-13.670.01-0.02-0.09-0.26
Other Operating Activities
0.130.550.45-0.01--
Change in Accounts Receivable
13.2313.21-0.2-0.94-0.17-0.55
Change in Inventory
0.790.61.590.420.231.01
Change in Accounts Payable
0.160.65-0.730.31-0.19-0.33
Change in Unearned Revenue
0.07-0.050.07-0.420.34-0.52
Change in Other Net Operating Assets
0.560.470.460.230.670.44
Operating Cash Flow
-0.140.15-0.41-0.7-0.41-0.25
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0-0.06-0.04-0.01-0.4-0.44
Sale (Purchase) of Intangibles
-0.08-0.08-0.25---
Investing Cash Flow
-0.08-0.14-0.29-0.01-0.4-0.44

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.260.030.030.031.18
Long-Term Debt Issued
-0.70.491.530.568.83
Total Debt Issued
0.130.960.521.560.5910.01
Short-Term Debt Repaid
-----0.22-0.56
Long-Term Debt Repaid
--1.26-0.55-1.49-2.14-4.85
Total Debt Repaid
-0.28-1.26-0.55-1.49-2.36-5.41
Net Debt Issued (Repaid)
-0.15-0.29-0.030.07-1.774.6
Financing Cash Flow
-0.15-0.29-0.030.07-1.774.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.050-0.070.03-0.25-0.01
Net Cash Flow
-0.32-0.28-0.8-0.61-2.833.9

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-0.140.09-0.44-0.71-0.81-0.69
Free Cash Flow Growth
------
Free Cash Flow Margin
-3.62%2.15%-9.81%-10.14%-10.01%-7.13%
Free Cash Flow Per Share
-0.010.02-0.26-2.10-7.72-7.46
Levered Free Cash Flow
1.111.050.38-0.170.85-0.64
Unlevered Free Cash Flow
1.171.120.470.041.12-0.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.060.070.090.090.140.22
Change in Working Capital
14.8114.871.19-0.40.880.05
SEC Filings: 10-K · 10-Q